Combined Plasma Levels of A-type-Natriuretic Peptide And Adrenomedullin Are Associated With Appropriate Anti-Arrhythmia Therapy in Patients With an Implantable Cardioverter Defibrillator but no prior Device Therapy

Farzin Beygui; Vincent Roule; Estelle Gandjbakhch; Pierre Ollitraut; Johanne Silvain; Paul Milliez; Nicolas Vignolles; Michel Zeitouni; Paul Guedeney; Laure Champ‐Rigot; Katrien Blanchart; Gilles Montalescot

doi:10.1080/1354750x.2025.2553630

August 29, 2025Biomarkers

Combined Plasma Levels of A-type-Natriuretic Peptide And Adrenomedullin Are Associated With Appropriate Anti-Arrhythmia Therapy in Patients With an Implantable Cardioverter Defibrillator but no prior Device Therapy

View at Publisher

Ask AI

Bookmark

Share

Key Points

Plasma levels of natriuretic peptide and adrenomedullin correlate with therapy appropriateness, highlighting their potential role.
Patients with higher levels showed better outcomes in anti-arrhythmia therapy, indicating a predictive value.
Assessment of plasma levels was performed in a cohort of patients with implantable cardioverter defibrillators.
Findings emphasize the importance of these biomarkers for managing arrhythmias in clinical settings.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Observational analysis links plasma levels of natriuretic peptide and adrenomedullin to anti-arrhythmia therapy outcomes in patients with defibrillators, suggesting clinical significance.

Abstract

Background

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Beygui et al. (2025) studied this question.

synapsesocial.com/papers/68c1d97d54b1d3bfb60fb1b1 https://doi.org/10.1080/1354750x.2025.2553630

View at Publisher

Ask AI

Bookmark

Share

Combined Plasma Levels of A-type-Natriuretic Peptide And Adrenomedullin Are Associated With Appropriate Anti-Arrhythmia Therapy in Patients With an Implantable Cardioverter Defibrillator but no prior Device Therapy

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Combined Plasma Levels of A-type-Natriuretic Peptide And Adrenomedullin Are Associated With Appropriate Anti-Arrhythmia Therapy in Patients With an Implantable Cardioverter Defibrillator but no prior Device Therapy

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading